By using disuccinimidyl suberate, we have covalently crosslinked 1251-labeled somatomedin-C (Sm-C)/insulinlike growth factor I to specific binding proteins in human plasma. In unfractionated plasma samples from normal and acromegalic donors, '251-Sm-C binding-protein complexes with relative molecular weights (Mr) of 160,000, 135,000, 110,000, 80,000, 50,000, 43,000-35,000, and 28,000-24,000 were consistently observed. In contrast, the 43,000-35,000-mol wt species were frequently the only specific complexes observed in hypopituitary plasma and were consistently more intensely labeled in such samples. Reduction of samples with ,B-mercaptoethanol did not alter the electrophoretic pattern of these '25I-Sm-C bindingprotein complexes. All Sm-C binding proteins, with the exception of the 43,000-35,000-mol wt complex, were adsorbed by concanavalin A-Sepharose. When acromegalic or normal plasma was fractionated on a Sephadex G-200 column and affinity labeled, the same complexes that were adsorbed by concanavalin A were found in fractions that eluted near the -y-globulin peak. On the other hand, the 43,000-35,000-mol wt complex consistently eluted in size-appropriate fractions near the albumin peak. These data suggest that the growth hormone (GH)-dependent Sm-C binding protein, represented by the 160,000-mol wt complex, is in some way composed of smaller species, i.e., the 135,000-, 110,000-, 80,000-, 50,000-, and 28,000-24,000-mol wt complexes. Acid incubation of plasma prior to Sephadex G-200 chromatography results in the elimination of specific '25I-Sm-C binding-protein complexes which elute near -globulin and a concurrent increase in the labeling intensity of the 28,000-24,000-mol wt complexes. We speculate, therefore, that each of the GH-dependent Sm-C binding-protein complexes represents an oligomer composed of 28,000-24,000-mol wt protomers. The 43,000-35,000-mol wt species is not dependent upon GH and appears to represent a different type of Sm-C binding protein.
Introduction
The molecular weight of somatomedin-C/insulinlike growth factor I (Sm-C/IGF-I)' is 7,649 (1, 2), but it circulates in the blood at much higher relative molecular weights (Mr - 150,000 and 40,000) because it is complexed with binding proteins (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) . The -y-globulin-sized (-150 ,000 mol wt), somatomedin binding protein is growth hormone (GH) dependent and is associated with the majority of circulating somatomedin (6-9, 11, [16] [17] [18] [19] . It is thought to be composed of at least two subunits (8) ; however, neither its structure nor that of the smaller (-40,000 mol wt) Sm-C binding protein is known.
Virtually all published studies have approached the characterization of plasma somatomedin binding proteins in one or both of two ways: evaluation of the elution pattern of radioactivity from gel filtration columns after incubation of labeled somatomedin and serum (3-12, 14-16, 18-21) , or assessment of binding activity by activated charcoal separation of free and bound labeled peptide after its incubation with serum (3, 6, 9-13, 15, 16, 18, 19, 21) . We have developed a technique to affinity-label circulating Sm-C binding-proteins using the cross-linking agent disuccinimidyl suberate (DSS) (22, 23) and now report its utility in studies of these proteins in postnatal human plasma. This technique utilizes sodium dodecyl sulfate (SDS) polyacrylamide gel electrophoresis (PAGE) to separate the covalently cross-linked '251-Sm-C binding-protein complexes, and hence provides greater resolution of Sm-C binding moieties than has heretofore been available. New insights resulting from this study have led us to propose that the GH-dependent, y-globulin-sized plasma Sm-C binding protein is an oligomer composed of identical subunits. The apparent Mr of the '251-Sm-C monomer complex is 28,000- 24 ,000.
Methods
Plasma samples. All blood samples were collected between 0900 and 1200 h by venipuncture into EDTA vacutainers (Becton-Dickinson & Co., Rutherford, NJ) from individuals on regular diets. They were immediately chilled on ice, separated by centrifugation within 2 h, and frozen at -20'C until use (usually within 4 wk). Immunoreactive Sm-C was determined on each plasma sample by a modified (7, 20) nonequilibrium technique (24) . Studies of normal plasma were performed on samples collected from healthy adult males. Acromegalic plasma samples were obtained from a number of individuals, but all the studies reported here represent samples obtained from a 12-yrold white boy whose diagnosis was based on a basal GH level of 11 ng/ml, a peak GH of 20 ng/ml 30 min after thyrotropin-releasing hormone infusion, and plasma immunoreactive Sm-C concentrations of between 8.1 and 11.2 U/ml. Transphenoidal exploration revealed an adenoma 8 mm in diameter. Hypopituitary plasma was obtained from a number of prepubertal children between the ages of 2-7/12 and 18-9/12 yr (four boys and four girls). All were significantly below the 3rd centile for height (2.9-6.0 SD below 50th centile), had growth nimidyl suberate; DTSSP, 3,3'-dithiobis(sulfosuccinimidyl propionate);
GH, growth hormone; hGH, human growth hormone; IGF-I, insulinlike growth factor I; PAGE, polyacrylamide gel electrophoresis; Sm-C, somatomedin-C.
velocities of <4.00 cm/yr (1.9-3.7 cm/yr), lacked a significant GH response to two different provocative stimuli (usually insulin-induced hypoglycemia and arginine), and had basal plasma Sm-C concentrations of <0.25 U/ml (0.03-0.23 U/ml). Collection of blood was approved by the Committee for Protection of Human Subjects, University of North Carolina at Chapel Hill.
Reagents. '25l-labeled somatomedin-C ('251I-Sm-C) had a specific activity of 200 MCi/Mg and was judged by multiple criteria to be no less than 90% pure (25) . The '251-Sm-C was stored at -20'C in 2% bovine serum albumin. For studies of binding specificity, purified Sm-C was used. When an excess of Sm-C was required, partially purified preparations obtained after isoelectrofocusing were used (25 by the addition of 10 Ml of 10 or 50 mM DSS dissolved in dimethyl sulfoxide to give a final concentration of 1 mM DSS, followed by incubation at room temperature for 10 min.
When 50 Ml of normal plasma dissolved in 0.5 ml of 0.05 M Na phosphate buffer (pH 7.4) was incubated with as little as 5 ng of unlabeled Sm-C in addition to '25I-Sm-C, labeling of specific Sm-C binding proteins was significantly reduced. Incubation with 100 ng of unlabeled Sm-C was sufficient to obliterate completely all specific labeling, whereas as much as 1 mg of insulin had no effect. Labeled bands were judged to be specific Sm-C binding proteins if they were abolished as a result of incubation with an excess of unlabeled Sm-C (25 ng/10 Ml plasma in a 1:10 dilution with buffer).
The parameters for incubation of '25I-Sm-C with plasma and the cross-linking procedure were determined experimentally by altering variables individually at first and later in concert to determine the conditions that consistently resulted in intensely labeled, specific bands and minimalized nonspecific labeling. The parameters studied were the dilution of plasma (1:1, 1:5, 1:10, 1:20 and 1:50), time (0.5 min to 18 h) of incubation, and concentration of DSS (0.25-5.0 mM), and temperature of cross-linking (0, 4, and 22-24°C). >1:10 dilution of whole plasma samples generally decreased the intensity of specifically labeled bands; on the other hand, plasma dilutions of <1:10 dramatically increased nonspecific labeling without an increase in the intensity of specifically labeled bands. The time of incubation of '25I-Sm-C and plasma at either 00 or 4°C did not alter results, but incubation at 22°-24°C increased nonspecific labeling. Concentrations of DSS between 0.5-1.0 mM maximized the intensity of specifically labeled bands. Higher DSS concentrations consistently resulted in an increase in nonspecific cross-linking and protein precipitation. The time allowed for the reaction was not critical, because the cross-linking reaction goes to completion in minutes. Plasma, rather than serum, was used in this study because the Sm-C binding proteins appeared to be more stable over time in plasma; however, no differences were observed when fresh plasma and serum were compared. Collection of plasma in Aprotinin 5-10 TIU/ml (Sigma Chemical Co., St. Louis, MO) or 0.1 mM phenylmethylsulfonyl fluoride did not alter results.
The cross-linking agents BS3, Sulfo-Sanpah, DTSSP, and DMS were tested under similar experimental conditions to explore the possibility that binding proteins could exist which were not affinity labeled by DSS, but might be labeled when an alternate cross-linker was used. Of those tested, BS3 and DTSSP were effective and produced electrophoretic patterns of cross-linked '25I-Sm-C binding-protein complexes identical to those generated by DSS.
PAGE and autoradiography. SDS-PAGE was performed on 7-15% linear gradient 16 X 1 7-cm slab gels according to the method of Janis et al. (26) with minor modifications. Gels were preelectrophoresed for at least 2 h with a constant power of 10 W/gel before loading samples. Electrophoresis was performed using the Tris-glycine buffer system of Laemmli (27) We also compared the number of counts per minute specifically bound to Sm-C binding proteins in normal plasma by both a charcoal binding assay (21) and by cross-linking with DSS. '251-Sm-C (100,000 cpm) was incubated with 5 ul of normal plasma in the absence and presence of unlabeled Sm-C (25 ng), cross-linked with 1 mM DSS, and subjected to SDS-PAGE. In parallel, 5 M1l of normal plasma was incubated with 100,000 cpm 1251I-Sm-C and the apparent bound and unbound counts per minute were separated with activated charcoal. Although only 7.9% of the total counts per minute added were crosslinked to bands representing specific Sm-C-binding-protein complexes, these specifically bound counts per minute exceeded the counts per minute that could be interpreted as bound in the charcoal binding assay by about threefold (7,800 cpm vs. 2,200-2,600).
Chromatography. Gel filtration chromatography was performed using a 1.6 X 90-cm (bed volume = 180 ml) Sephadex G-200 Superfine (Pharmacia Fine Chemicals, Piscataway, NJ) column. Plasma samples (0.5 ml) were eluted at 4VC in 0.1 M Na phosphate buffer (pH 7.2) containing 0.01 M NaCl and collected in l-ml fractions which were monitored for protein by determination of optical density at 280 nm. Aliquots (200 ,ul) taken from selected column fractions (usually every other) were affinity labeled with 1251-Sm-C (150,000 cpm) after chromatography in the presence or absence of unlabeled Sm-C as described above, and subjected to SDS-PAGE. In other experiments, 0.5-ml plasma samples were incubated with '251-Sm-C (60,000 cpm) before chromatography. Fractions were counted in a gamma counter and aliquots (50-100 ,ul) assayed to determine the migration of endogenous immunoreactive Sm-C. In one experiment, a 0.5-ml sample of normal plasma was affinity labeled with '251-Sm-C (2.5 X 106 cpm) in a total volume of 5.0 ml before gel chromatography and 100-M1 aliquots from selected fractions were subjected to SDS-PAGE. In another experiment, X 70-cm (bed volume = 372 ml) column equilibrated in 0.05 M NaPO4, pH 7.4.
Concanavalin A (Con A)-Sepharose (Pharmacia Fine Chemicals) affinity chromatography was performed on a 1.2 X 15-cm (bed volume = 10 ml) column. Plasma samples (0.5 ml) were eluted at 4VC in 0.05 M Na phosphate buffer (pH 7.0) containing 0.1 M NaCl (40 ml). The column was washed with an additional 40 ml of buffer, and the adsorbed proteins were subsequently eluted in the starting buffer containing 0.5 M a-methyl-D-mannoside (Sigma Chemical Co.). Aliquots (200 Al) from the Con A fractions were affinity labeled with 125I-Sm-C (150,000 cpm) after chromatography in the presence or absence of excess unlabeled Sm-C as described above. In other experiments, plasma samples were affinity labeled with 1251-Sm-C (3 X 106 cpm) before Con A fractionation.
Results
Affinity-labeled Sm-C binding-protein complexes in whole plasma When whole plasma samples were incubated with 1251I-Sm-C and cross-linked, a number of specifically labeled Sm-C bindingprotein complexes were observed ( Fig. 1 shows a representative autoradiogram). In acromegalic plasmas, the most intensely labeled complexes migrated as doublets with apparent Mr of 28,000-24,000 and 43,000-35,000. More faintly labeled complexes were observed with apparent M, of 50,000, 80,000, 110,000, 135,000, and 160,000. In normal plasmas, the pattern of specific '251I-Sm-C binding-protein was similar; however, the labeling of the 28,000-24,000-mol wt doublets and the complexes with M, of 80,000 and greater was less intense. The 43,000-35,000-mol wt complexes appeared as triplets and were more intensely labeled than in the acromegalic samples. In hypopituitary plasmas, the 28,000-24,000-mol wt doublets and the complexes Mr of 80,000 and greater were either only faintly visible or not observed. These plasmas exhibited the most intensely labeled 43,000-35,000-mol wt complexes, which again appeared as triplets. The 50,000-mol wt complexes were somewhat less intensely labeled than in acromegalic and normal plasma samples.
When the incubation of '25I-Sm-C and plasma was carried out in the presence of an excess of unlabeled Sm-C, a number of autoradiographic bands were neither abolished nor diminished in intensity. Bands near the bottom of all lanes (Mr of 14,000) probably represent dimers of the 1251-Sm-C molecule resulting from the iodination procedure, because they were also observed when '25I-Sm-C alone was subjected to SDS-PAGE. Diffuse and noncompetitive labeling was observed in the regions between 50,000 and 70,000 mol wt and between 135,000 and 160,000 mol wt ( Figs. 1 and 2) . Much of the labeling in these areas apparently represented nonspecific interaction of 125I-Sm-C and scavenger proteins because they either appeared or increased in intensity when '25I-Sm-C was displaced from its specific binding proteins by unlabeled Sm-C. Reduction of samples with 2% (3-mercaptoethanol prior to SDS-PAGE did not alter the electrophoretic pattern of the specifically labeled plasma Sm-C binding-protein complexes. When whole plasma samples (diluted 1:10 in NaPO4 buffer, pH 7.4) were heated at temperatures of up to 60°C for 20 min, the specific Sm-C binding proteins retained the capacity to bind '251-Sm-C; however, temperatures of 65°C and greater for 20 min destroyed the binding activity.
Inasmuch the GH secretory status of the blood donor appeared to be an important determinant of which '251-Sm-C binding-protein complexes were observed, the influence of GH secretory status was further studied. Plasma samples from hypopituitary children obtained before and during human growth hormone (hGH) treatment were affinity labeled and subjected to SDS-PAGE (Fig. 2) (Fig. 3) . Of these complexes, the 160,000-, 50,000-, and 24,000-mol wt species were the most intensely labeled. The smaller complexes, i.e., the 50,000-, 43,000-35,000-, and 24,000-mol wt species, were also observed in size-appropriate column fractions (i.e., their migration during gel filtration was consistent with their apparent Mr as determined by SDS-PAGE) and account for the second peak of '25I-Sm-C binding activity. The 50,000-and 24,000-mol wt species had two distinct peaks of labeling intensity which were coincident with the 251I-Sm-C binding activity peaks ( Fig. 3, insets; contrast the labeling intensity of these species in fractions 51 and 64 with their labeling in fraction 58). On the other hand, the 43,000-35,000-mol wt species eluted as a broad peak with the most intense labeling occurring near the albumin peak ( Fig. 3, insets; note the similar labeling intensity of the 43,000-35,000-mol wt species in fractions 51, 58 and 64; fractions 60-62, not shown, contained the most intensely labeled 43,000-35,000-mol wt species). When normal plasma was fractionated, the elution pattern of the specific Sm-C binding-protein complexes was similar to that of acromegalic plasma ( Fig. 4, insets ; affinity labeled after G-200 chromatography). However, in normal plasma labeled 43,000-35,000-mol wt complexes were nearly absent in fractions from the peak of 1251I-Sm-C binding activity eluting near y-globulin, but were intensely labeled in fractions eluting just after the albumin peak. Together with the 50,000-and 24,000-mol wt species, these binding proteins appear to account for the second peak of '25I-Sm-C binding activity observed in both acromegalic and normal plasma. That a portion of the 43,000-35,000-mol wt binding species eluted with the -y-globulin-sized binding proteins in acromegalic plasma is not readily apparent, but may be due to nonspecific protein-protein associations.
The single 1251I-Sm-C binding activity peak of hypopituitary plasma that eluted slightly after albumin contained intensely labeled 43,000-35,000-mol wt complexes and very faintly labeled bands representing the 50,000-and 24,000-mol wt complexes (Fig. 5) . The higher molecular weight '251-Sm-C binding-protein complexes present in the -y-globulin fractions of both acromegalic and normal plasma were not observed in hypopituitary plasma; however, very faintly labeled 50,000-and 24,000-mol wt complexes were detected in these fractions. Because all labeled Sm-C binding-protein complexes did not migrate in a size-appropriate fashion during Sephadex G-200 column chromatography, normal plasma was affinity labeled before Sephadex G-200 chromatography to determine if the affinity-labeled complexes migrate aberrantly under these conditions as well. Cross-linked '251I-Sm-C binding-protein complexes eluted predominantly in size-appropriate Sephadex column fractions (Fig. 4, top inset: affinity labeled before G-200 chromatography); specifically, 'y-globulin-sized column fractions contained only very faint bands of <80,000-mol wt cross-linked complexes. These results imply that cross-linked '251-Sm-C binding-protein complexes do not migrate aberrantly on Sephadex G-200 columns. In addition, these results suggest that covalent cross-linking of each entity comprising the 160,000-mol wt complex is necessary for this complex to remain intact during SDS electrophoresis. SDS-PAGE may not by itself, however, account for the <80,000-mol wt complexes observed in y-globulin-sized column fractions, in that events occurring during or after column chromatography, but before cross-linking, such as dilution or proteolysis, could result in the dissociation of the 160,000-mol wt complex.
Because Sm-C binding proteins can be freed of the bound peptide by acidification, normal plasma was incubated in 0.1 M glycine-HCl, pH 3.6 (ionic strength 0.05) (20) and then subjected to Sephadex G-200 chromatography under neutral conditions (Fig. 6) . Acidification resulted in the apparent elimination of the specifically labeled Sm-C binding-protein complexes with Mr greater than or equal to 50,000, i.e., those complexes which previously eluted with the y-globulin peak.
Acid treatment also resulted in an apparent increase in nonspecific binding of 1251I-Sm-C, particularly in the proteins with Mr > 100,000 (see Fig. 6 , inset at fraction 90, for example). The specific binding activity of the 43,000-35,000-and 28,000-24,000-mol wt complexes was preserved. The 43,000-35,000-mol wt complexes eluted in a narrow peak immediately after albumin. These complexes, which had appeared as a triplet when nonacid-treated plasma was studied, now appeared on autoradiograms as a broad band with M, of 45,000-30,000, suggesting that they had sustained some damage as a result of acidification. After acid treatment, the 28,000-24,000-mol wt band, which had eluted in two distinct peaks in nonacidtreated plasma (both with the y-globulin-sized proteins and in size-appropriate fractions), appeared as a single broad, sizeappropriate peak whose labeling intensity was markedly increased. As expected, the immunoreactive Sm-C eluted as the free peptide. 
Discussion
Specific Sm-C binding-protein complexes have been identified in human plasma by affinity labeling with '25I-Sm-C using the homobifunctional cross-linking agent DSS and separating the products by SDS-PAGE. These complexes can be distinguished from each other by several criteria: apparent Mr, GH dependence, behavior on Sephadex G-200, and affinity for Con ASepharose (Table I) . Consistent with the findings of others (6-11, 16-19), our observations suggest that two types of circulating somatomedin binding proteins can be distinguished on the basis of their GH dependence. A GH-dependent somatomedin binding protein has been shown to elute near the y-globulin peak during gel filtration chromatography (6-11, 16, 18, 19) . In these column fractions from either acromegalic or normal plasma, we observed not only specific 1251I-Sm-C binding-protein complexes similar in size to y-globulin (apparent M, of 160,000 and 135,000), but also smaller complexes with apparent M, of 110,000, 80,000, 50,000, and 28,000-24,000. These complexes account for the GH-dependent y-globulin peak of 125I-Sm-C binding activity inasmuch as identical column fractions from hypopituitary plasmas contained either no specifically labeled complexes or only faintly labeled representatives of the 50,000 and 28,000-24,000-mol wt species. The relative labeling intensity of each of these complexes in acromegalic, normal, and hypopituitary whole plasma (more intense labeling in acromegalic than normal plasma, and either faint or no labeling in hypopituitary plasma) and the finding that some of these complexes appear in the plasma of hypopituitary children undergoing GH therapy provides strong evidence of their GH dependency. On the other hand, the 43,000-35,000-mol wt 125I-Sm-C binding-protein complexes did not appear to be GH dependent, in that they were present in all plasma samples regardless of the GH status of the donor. These complexes generally eluted slightly after the albumin peak during gel filtration and did not appear to be associated with the GHdependent complexes that migrated near the y-globulin peak.
The 43,000-35,000-mol wt complexes account for the non-GH dependent 1251-Sm-C binding activity reported by others (6-11), but in normal and acromegalic plasma the 50,000-and 28,000-24,000-mol wt GH-dependent binding species also contribute to this binding peak. In addition, we were able to separate the two types of Sm-C binding proteins by Con A affinity chromatography. The GH-dependent Sm-C binding complexes (i.e., 160,000, 135,000, 110,000, 80,000, 50,000, and 28,000-24,000 mol wt) were adsorbed by Con A, whereas the non-GH-dependent species (43,000-35,000 mol wt) eluted in the void volume.
Affinity labeling of specific Sm-C binding-protein complexes is by definition reduced or abolished in the presence of sufficiently high concentrations of unlabeled Sm-C because the binding of '251-Sm-C to these proteins is largely determined by binding site occupancy. We observed that concentrations of unlabeled Sm-C in the range of those found in plasma (nanomolar) consistently reduce the labeling intensity of all specific '251I-Sm-C binding-protein complexes. This suggests that endogenous plasma Sm-C concentrations influence the labeling intensity of specific binding complexes.
The labeling intensity of the 43,000-35,000-mol wt species is inversely proportional to the plasma Sm-C concentration of the blood donor, i.e., most intense in hypopituitary plasma and least intense in acromegalic plasma. Furthermore, there is a marked decrease in their labeling intensity after plasma Sm-C concentrations are normalized in hypopituitary children by GH treatment. Nonetheless, the 43,000-35,000-mol wt complexes are intensely labeled in all plasmas studied, suggesting that these species are relatively unsaturated regardless of plasma Sm-C concentrations. This concept is supported by the observations that only a small portion of the endogenous somatomedin migrates with the 43,000-35,000-mol wt species during gel chromatography (6-10, 13, 18, 19) , but when '25I-Sm-C is incubated with normal plasma prior to chromatography, the majority of the bound label elutes in the 43,000-35,000 mol wt range.
Consistent with our findings and those of others (5-7, 13, 20, 21) , Furlanetto (8) has reported that 95% of the immunoreactive Sm-C in normal serum is associated with GH-dependent, y-globulin-sized binding activity that is adsorbed by Con A-Sepharose. That the majority of endogenous Sm-C is associated with the GH-dependent binding species strongly suggests that these proteins have a higher affinity for Sm-C than the non-GH-dependent species. This is also consistent with the findings of Binoux et al. (12) , who reported that human serum contains two binding proteins that exhibit different affinities for the somatomedins: one exhibiting a higher affinity for Sm-C/IGF-I was the predominant binding species in the 100,000-170,000 mol wt range, whereas a binding protein with a selective affinity for IGF-II predominated in the 40,000-70,000 mol wt range. Confirmation of this hypothesis will require competition studies using homogeneous preparations of the different binding proteins.
There are some problems inherent in studies that employ chemical cross-linking agents (28 (23) and found that they bear remarkable similarity to those observed in human plasma. Normal rat sera exhibited Sm-C binding species with Mr of 95,000, 26,000-23,000, and possibly a series of complexes ranging from 175,000 to 115,000, none of which were observed in hypophysectomized rat sera. These complexes are analogous to the GH-dependent Sm-C binding proteins in human plasma. Hypophysectomized rat serum contained only a 36,000-33,000-mol wt doublet, which appears homologous to the 43,000-35,000-mol wt non-GH-dependent species observed in human plasma. Using an alternative crosslinking procedure (30), Schwander et al. (31) have reported a 35,000-mol wt IGF-I binding protein in rat liver perfusates, whereas Hossenlopp et al. (32) reported an IGF-I binding protein in both cultured rat and human liver media which migrated as doublet bands between 37,000 and 40,000 mol wt. A multiplication-stimulating activity carrier protein of similar size has been purified from conditioned media of the rat liver cell line, BRL-3A, by Knauer et al. (33) . In addition, we have also observed affinity-labeled complexes with apparent Mr of 45,000-35,000 in human cord plasma and amniotic fluid (22) .
In the present study, we consistently labeled multiple Sm-C binding proteins (complexes with apparent Mr of 160,000, 135,000, 110,000, 80,000, 50,000, and 28,000-24,000) in fractions that elute near the 'y-globulin peak during G-200 Sephadex chromatography. These observations indicate that each of these species is in some way associated with the yglobulin-sized, GH-dependent '25I-Sm-C binding activity. Indeed, the co-migration of the 160,000-mol wt complex and the smaller species strongly suggests that the native -y-globulinsized binding protein is a complex that dissociates to generate the pattern of labeled species we have observed on SDS gels. It is not clear whether the 1 60,000-mol wt complex dissociates as a result of instability in a dilute solution (i.e., dissociation during and after chromatography but before cross-linking) or as a consequence of the SDS treatment followed by electrophoretic separation. These two possibilities are, of course, not mutually exclusive, and we suspect that both occur. The finding that the <160,000-mol wt complexes migrated predominately in size-appropriate column fractions when plasma was labeled before G-200 chromatography suggests that these complexes circulate free in plasma. It seems possible, therefore, that an equilibrium exists in plasma between the 160,000-mol wt complex and the smaller binding species, such that dilution during column chromatography favors a dissociation of the 1 60,000-mol wt complex into its constituent subunits, as previously suggested by Daughaday et al. (13) . Dissociation of subunits could also expose more Sm-C/IGF-I binding sites and, thus, explain the increased binding in the y-globulin fractions of chromatographed human serum observed by White et al. (19) when they studied binding after elution.
Many studies have documented that acidification of plasma effects a dissociation of Sm-C and its binding proteins (3, 5, 6, 8, 17, 20, 21) . Our data, like those of others (8, 18, 33) , indicate that acidification dissociates the GH-dependent Sm-C binding protein into subunits. After acidification, normal plasma exhibited only two specific Sm-C binding-protein complexes: the non-GH-dependent 43,000-35,000-mol wt complex and the GH-dependent 28,000-24,000-mol wt species. The migration of the 43,000-35,000-mol wt complex during Sephadex G-200 chromatography was essentially unchanged by acidification, although the diffuse labeling of these complexes indicates that they may be unstable under acidic conditions.
On the other hand, the 28,000-24,000-mol wt complex eluted in size-appropriate fractions as a single broad peak. The acidmediated destruction of the y-globulin-sized Sm-C binding protein complex and the concurrent increase in the labeling intensity of the 28,000-24,000-mol wt complexes suggests that the 28,000-24,000-mol wt complex is the Sm-C binding subunit of the 160,000-mol wt, GH-dependent binding-protein complex.
Furlanetto (8) Using DMS to study subunit structure of oligomeric proteins, they clearly showed that the number of principal species observed is identical to the number of protomers in the native oligomer. The 28,000-24,000-, 50,000-, and 160,000-mol wt complexes that we observed were consistently the most intensely labeled binding proteins eluting in the 'v-globulin-sized peak of '25I-Sm-C binding activity, while the 110,000-and 80,000-mol wt species in the same fractions were often only faintly labeled. The precise reason(s) for the differences in labeling intensity among the putative oligomers is unknown. One cause may be the ineffectiveness of DSS in cross-linking protomers that are arranged in certain conformations. For example, some protomers, or the 1251-Sm-C molecules they bind, may not be accessible for cross-linking, resulting in complexes with aggregated but uncross-linked protomers or in complexes not covalently crosslinked to 1251-Sm-C. It has been suggested that a portion of the circulating immunoreactive Sm-C is unavailable for the antibody/antigen reaction because of the manner in which it is complexed with binding proteins (20, 21) . Perhaps the same factors that prevent the detection of immunoreactive Sm-C could also prevent cross-linking of the binding protein in certain steric arrangements. This could in turn affect labeling intensity. Another explanation for the labeling differences among the GH-dependent binding species may be that certain complexes, as the 110,000-and 80,000-mol wt species, are intrinsically unstable or labile intermediate forms of the 160,000-mol wt GH dependent complex. Alternatively, each complex may have a unique affinity for Sm-C.
Although consistent with all our findings, our conclusions as to the composition of the GH-dependent, '-globulin-sized Sm-C binding protein remain speculative. Alternative hypotheses are that the GH-dependent complexes we observed are the result of partial proteolysis of the native 160,000-mol wt binding protein or that each represents a unique binding protein induced by GH. In future experiments, we will attempt to demonstrate involvement of the 28,000-24,000-mol wt subunit in the native 160,000-mol wt Sm-C binding-protein complex by immunologic means.
